Importance of establishing the presence of drug active metabolites Silvio Garattini Review Paper Pages: 97 - 108
Comparison of the plasma and urinary metabolites of [3H]-econazole nitrate in the monkey and pregnant and non-pregnant rat R. GirkinR. R. BrodieL. F. Chasseaud Original Papers Pages: 109 - 116
Disposition and metabolism of [3H]gliclazide in rats Hisashi MiyazakiToshihiko FujiiNanaya Tamaki Original Papers Pages: 117 - 131
Acetylation character of isoniazid in the rabbit and in man M. F. KerguerisCl. LarousseM. Bourin Original Papers Pages: 133 - 136
Pharmacokinetics and biotransformation of the prostacyclin analogue, ZK 36 374 I. Synthesis of a tritium marker and excretion of [3H]-ZK 36 374 in the rat W. KrauseW. SkuballaP. E. Schulze Original Papers Pages: 137 - 144
Pharmacokinetics and biotransformation of the prostacyclin analogue, ZK 36 374 II. Blood and plasma levels and passage of the blood/brain barrier in the rat W. KrauseM. Schubert Original Papers Pages: 145 - 150
Enzymology of the metabolic pathway from nicotine to cotinine,in vitro A. R. HibberdJ. W. Gorrod Original Papers Pages: 151 - 162
Structural investigation of a new organic antiseptic: Taurolidine F. ErbM. ImbenotteR. W. Pfirrmann Original Papers Pages: 163 - 173
Fluvoxamine maleate; Disposition in man H. De BreeJ. B. Van Der SchootL. C. Post Original Papers Pages: 175 - 179
Differential consequences of renal failure on the pharmacokinetics of Oxprenolol and its main metabolite P. DayerPh. GlassonJ. Fabre Original Papers Pages: 181 - 188
Dose-dependent pharmacokinetics of sulpirideand sulpiride-induced prolactin secretionin man F. R. SugnauxA. BenakisR. Di Carlo Original Papers Pages: 189 - 200
EPA Symposium on SAFER CHEMICALS THROUGH MOLECULAR DESIGN Hyatt Regency, Arlington, Virgina — Sept. 11–15, 1983 Announcement Pages: 205 - 206